{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T14:50:43Z","timestamp":1787237443342,"version":"build-2736575974"},"reference-count":44,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100004160","name":"Mazandaran University of Medical Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004160","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Microbial Pathogenesis"],"published-print":{"date-parts":[[2020,10]]},"DOI":"10.1016\/j.micpath.2020.104406","type":"journal-article","created":{"date-parts":[[2020,7,29]],"date-time":"2020-07-29T21:57:21Z","timestamp":1596059841000},"page":"104406","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Apoptotic blebs from Leishmania major-infected macrophages as a new approach for cutaneous leishmaniasis vaccination"],"prefix":"10.1016","volume":"147","author":[{"given":"Roghiyeh","family":"Faridnia","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hamed","family":"Kalani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hajar Ziaei","family":"Hezarjaribi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5051-1613","authenticated-orcid":false,"given":"Paul W.","family":"Denny","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alireza","family":"Rafie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahdi","family":"Fakhar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stela","family":"Virgilio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.micpath.2020.104406_bib1","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1172\/JCI33945","article-title":"Kinetoplastids: related protozoan pathogens, different diseases","volume":"118","author":"Stuart","year":"2008","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.micpath.2020.104406_bib2","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/S1473-3099(07)70209-8","article-title":"Cutaneous leishmaniasis","volume":"7","author":"Reithinger","year":"2007","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.micpath.2020.104406_bib3","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1016\/S0140-6736(18)31204-2","article-title":"Leishmaniasis","volume":"392","author":"Burza","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/j.micpath.2020.104406_bib4","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.jgar.2018.09.004","article-title":"Potent in vitro antileishmanial activity of a nanoformulation of cisplatin with carbon nanotubes against Leishmania major","volume":"16","author":"Akhtari","year":"2019","journal-title":"J Glob Antimicrob Resist"},{"key":"10.1016\/j.micpath.2020.104406_bib5","first-page":"29","article-title":"Investigating in vitro anti-leishmanial effects of silibinin and silymarin on Leishmania major","volume":"64","author":"Faridnia","year":"2018","journal-title":"Ann Parasitol"},{"key":"10.1016\/j.micpath.2020.104406_bib6","doi-asserted-by":"crossref","first-page":"151","DOI":"10.3389\/fimmu.2016.00151","article-title":"Cutaneous leishmaniasis vaccination: a matter of quality","volume":"7","author":"De Luca","year":"2016","journal-title":"Front. Immunol."},{"key":"10.1016\/j.micpath.2020.104406_bib7","doi-asserted-by":"crossref","first-page":"e13","DOI":"10.1038\/cti.2014.4","article-title":"Vaccines to prevent leishmaniasis","volume":"3","author":"Kumar","year":"2014","journal-title":"Clin Transl Immunol"},{"key":"10.1016\/j.micpath.2020.104406_bib8","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.ijpddr.2019.05.003","article-title":"Mining for natural product antileishmanials in a fungal extract library","volume":"11","author":"Mbekeani","year":"2019","journal-title":"Int J Parasitol Drugs Drug Resist"},{"key":"10.1016\/j.micpath.2020.104406_bib9","doi-asserted-by":"crossref","first-page":"95","DOI":"10.4103\/ijpvm.IJPVM_116_18","article-title":"Leishmania vaccines entered in clinical trials: a review of literature","volume":"10","author":"Moafi","year":"2019","journal-title":"Int. J. Prev. Med."},{"key":"10.1016\/j.micpath.2020.104406_bib10","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1016\/j.vaccine.2012.11.065","article-title":"Leishmanization revisited: immunization with a naturally attenuated cutaneous Leishmania donovani isolate from Sri Lanka protects against visceral leishmaniasis","volume":"31","author":"McCall","year":"2013","journal-title":"Vaccine"},{"issue":"11","key":"10.1016\/j.micpath.2020.104406_bib11","doi-asserted-by":"crossref","first-page":"2890","DOI":"10.1038\/jid.2015.236","article-title":"IL-10 signaling in dendritic cells attenuates anti-Leishmania major immunity without affecting protective memory responses","volume":"135","author":"Girard-Madoux","year":"2015","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.micpath.2020.104406_bib12","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1586\/14760584.2014.894467","article-title":"Identifying vaccine targets for anti-leishmanial vaccine development","volume":"13","author":"Sundar","year":"2014","journal-title":"Expet Rev. Vaccine"},{"key":"10.1016\/j.micpath.2020.104406_bib13","doi-asserted-by":"crossref","first-page":"e1006349","DOI":"10.1371\/journal.ppat.1006349","article-title":"Skin-resident CD4+ T cells protect against Leishmania major by recruiting and activating inflammatory monocytes","volume":"13","author":"Glennie","year":"2017","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.micpath.2020.104406_bib14","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1038\/nm1108","article-title":"Central memory T cells mediate long-term immunity to Leishmania major in the absence of persistent parasites","volume":"10","author":"Zaph","year":"2004","journal-title":"Nat. Med."},{"key":"10.1016\/j.micpath.2020.104406_bib15","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1080\/14760584.2018.1459191","article-title":"Vaccine candidates against leishmania under current research","volume":"17","author":"Iborra","year":"2018","journal-title":"Expert Rev. Vaccines"},{"key":"10.1016\/j.micpath.2020.104406_bib16","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1586\/14760584.7.8.1277","article-title":"Cutaneous leishmaniasis: progress towards a vaccine","volume":"7","author":"Launois","year":"2008","journal-title":"Expert Rev. Vaccines"},{"key":"10.1016\/j.micpath.2020.104406_bib17","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.jaut.2007.07.017","article-title":"Innate and adaptive immune response to apoptotic cells","volume":"29","author":"Peng","year":"2007","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.micpath.2020.104406_bib18","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1155\/2017\/9042851","article-title":"Phagocytosis: a fundamental process in immunity","volume":"2017","author":"Rosales","year":"2017","journal-title":"BioMed Res. Int."},{"key":"10.1016\/j.micpath.2020.104406_bib19","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.coi.2009.01.001","article-title":"MHC molecules and microbial antigen processing in phagosomes","volume":"21","author":"Ramachandra","year":"2009","journal-title":"Curr. Opin. Immunol."},{"key":"10.1016\/j.micpath.2020.104406_bib20","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0182126","article-title":"Dendritic cells that phagocytose apoptotic macrophages loaded with mycobacterial antigens activate CD8 T cells via cross-presentation","volume":"12","author":"Espinosa-Cueto","year":"2017","journal-title":"PloS One"},{"key":"10.1016\/j.micpath.2020.104406_bib21","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1038\/nri.2016.72","article-title":"Cutaneous leishmaniasis: immune responses in protection and pathogenesis","volume":"16","author":"Scott","year":"2016","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.micpath.2020.104406_bib22","series-title":"Cancer Cell Culture: Methods and Protocols","first-page":"309","article-title":"Cell culture contamination","author":"Langdon","year":"2004"},{"key":"10.1016\/j.micpath.2020.104406_bib23","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/0003-2697(76)90527-3","article-title":"A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding","volume":"72","author":"Bradford","year":"1976","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.micpath.2020.104406_bib24","first-page":"265","article-title":"Evaluation of proliferation and cytokines production by mitogen-stimulated bovine peripheral blood mononuclear cells","volume":"6","author":"Norian","year":"2015","journal-title":"Vet. Res. Forum"},{"key":"10.1016\/j.micpath.2020.104406_bib25","doi-asserted-by":"crossref","first-page":"303","DOI":"10.4103\/0976-500X.119726","article-title":"How to calculate sample size in animal studies?","volume":"4","author":"Charan","year":"2013","journal-title":"J. Pharmacol. Pharmacother."},{"key":"10.1016\/j.micpath.2020.104406_bib26","doi-asserted-by":"crossref","first-page":"2460","DOI":"10.1096\/fj.06-5860com","article-title":"Skin mast cells control T cell-dependent host defense in Leishmania major infections","volume":"20","author":"Maurer","year":"2006","journal-title":"FASEB J."},{"key":"10.1016\/j.micpath.2020.104406_bib27","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1186\/s13071-016-1553-y","article-title":"Possibilities and challenges for developing a successful vaccine for leishmaniasis","volume":"9","author":"Srivastava","year":"2016","journal-title":"Parasites Vectors"},{"key":"10.1016\/j.micpath.2020.104406_bib28","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/j.pt.2019.04.002","article-title":"CD4+ T cell-mediated immunity against the phagosomal pathogen leishmania: implications for vaccination","volume":"35","author":"Hohman","year":"2019","journal-title":"Trends Parasitol."},{"key":"10.1016\/j.micpath.2020.104406_bib29","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1182\/blood-2009-10-250993","article-title":"Vaccination with synthetic analog peptides derived from WT1 oncoprotein induces T-cell responses in patients with complete remission from acute myeloid leukemia","volume":"116","author":"Maslak","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.micpath.2020.104406_bib30","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1128\/CDLI.8.5.880-883.2001","article-title":"Human lymphocyte proliferation responses following primary immunization with rabies vaccine as neoantigen","volume":"8","author":"Ghaffari","year":"2001","journal-title":"Clin. Diagn. Lab. Immunol."},{"key":"10.1016\/j.micpath.2020.104406_bib31","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/j.ajme.2018.10.004","article-title":"Comparison of immunogenical potency of Leishmania major (MRHO\/IR\/75\/ER) antigens prepared by 3 different methods in conjunction with Alum-Naltrexone adjuvant in BALB\/c mice","volume":"54","author":"Khezri","year":"2018","journal-title":"Alexandria J. Med."},{"key":"10.1016\/j.micpath.2020.104406_bib32","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1111\/jdv.14890","article-title":"The measurement of drug-induced interferon gamma-releasing cells and lymphocyte proliferation in severe cutaneous adverse reactions","volume":"32","author":"Suthumchai","year":"2018","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"10.1016\/j.micpath.2020.104406_bib33","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1016\/j.micinf.2008.06.002","article-title":"Vaccination with the Leishmania major ribosomal proteins plus CpG oligodeoxynucleotides induces protection against experimental cutaneous leishmaniasis in mice","volume":"10","author":"Iborra","year":"2008","journal-title":"Microbes Infect"},{"key":"10.1016\/j.micpath.2020.104406_bib34","doi-asserted-by":"crossref","first-page":"4486","DOI":"10.1016\/j.vaccine.2017.05.067","article-title":"A novel combination adjuvant platform for human and animal vaccines","volume":"35","author":"Garg","year":"2017","journal-title":"Vaccine"},{"key":"10.1016\/j.micpath.2020.104406_bib35","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1038\/32183","article-title":"Dendritic cells acquire antigen from apoptotic cells and induce class I-restricted CTLs","volume":"392","author":"Albert","year":"1998","journal-title":"Nature"},{"key":"10.1016\/j.micpath.2020.104406_bib36","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1038\/79470","article-title":"Targeted antigen delivery to antigen-presenting cells including dendritic cells by engineered Fas-mediated apoptosis","volume":"18","author":"Chattergoon","year":"2000","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.micpath.2020.104406_bib37","doi-asserted-by":"crossref","first-page":"4108","DOI":"10.1182\/blood-2002-05-1389","article-title":"Stressed apoptotic tumor cells stimulate dendritic cells and induce specific cytotoxic T cells","volume":"100","author":"Feng","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.micpath.2020.104406_bib38","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.meegid.2019.01.005","article-title":"Protection induced by Leishmania Major antigens and the imiquimod adjuvant encapsulated on liposomes in experimental cutaneous leishmaniasis","volume":"70","author":"Mehravaran","year":"2019","journal-title":"Infect. Genet. Evol."},{"key":"10.1016\/j.micpath.2020.104406_bib39","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/j.vaccine.2018.11.052","article-title":"Transcutaneous immunization using SLA or rLACK skews the immune response towards a Th1 profile but fails to protect BALB\/c mice against a Leishmania major challenge","volume":"37","author":"Lakhal-Naouar","year":"2019","journal-title":"Vaccine"},{"key":"10.1016\/j.micpath.2020.104406_bib40","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1038\/nm1592","article-title":"Multifunctional TH1 cells define a correlate of vaccine-mediated protection against Leishmania major","volume":"13","author":"Darrah","year":"2007","journal-title":"Nat. Med."},{"key":"10.1016\/j.micpath.2020.104406_bib41","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2013.00156","article-title":"Interferon gamma in leishmaniasis","volume":"4","author":"Kima","year":"2013","journal-title":"Front. Immunol."},{"key":"10.1016\/j.micpath.2020.104406_bib42","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.4049\/jimmunol.1701597","article-title":"CD8(+) T cells lack local signals to produce IFN-\u03b3 in the skin during leishmania infection","volume":"200","author":"Novais","year":"2018","journal-title":"J. Immunol."},{"key":"10.1016\/j.micpath.2020.104406_bib43","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/S0165-2478(00)00280-7","article-title":"Susceptibility to Leishmania major infection in the absence of IL-4","volume":"75","author":"Noben-Trauth","year":"2000","journal-title":"Immunol. Lett."},{"key":"10.1016\/j.micpath.2020.104406_bib44","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.molimm.2013.08.008","article-title":"Gene expression profile of cytokines and chemokines in skin lesions from Brazilian Indians with localized cutaneous leishmaniasis","volume":"57","author":"Costa-Silva","year":"2014","journal-title":"Mol. Immunol."}],"container-title":["Microbial Pathogenesis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0882401020307725?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0882401020307725?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T15:37:54Z","timestamp":1760110674000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0882401020307725"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10]]},"references-count":44,"alternative-id":["S0882401020307725"],"URL":"https:\/\/doi.org\/10.1016\/j.micpath.2020.104406","relation":{},"ISSN":["0882-4010"],"issn-type":[{"value":"0882-4010","type":"print"}],"subject":[],"published":{"date-parts":[[2020,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Apoptotic blebs from Leishmania major-infected macrophages as a new approach for cutaneous leishmaniasis vaccination","name":"articletitle","label":"Article Title"},{"value":"Microbial Pathogenesis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.micpath.2020.104406","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"104406"}}